Camlin Fine Sciences Limited (NSE:CAMLINFINE)
India · Delayed Price · Currency is INR 271.20
+3.75 (1.40%)
Aug 1, 2025, 3:30 PM IST
Accolade Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 16,665 | 14,539 | 16,816 | 14,121 | 11,871 | Upgrade | |
Revenue Growth (YoY) | 14.62% | -13.54% | 19.08% | 18.95% | 13.15% | Upgrade |
Cost of Revenue | 8,884 | 8,004 | 8,442 | 7,855 | 6,037 | Upgrade |
Gross Profit | 7,781 | 6,535 | 8,374 | 6,266 | 5,834 | Upgrade |
Selling, General & Admin | 2,129 | 1,710 | 1,816 | 1,582 | 1,298 | Upgrade |
Other Operating Expenses | 3,563 | 2,721 | 4,395 | 3,154 | 2,565 | Upgrade |
Operating Expenses | 6,331 | 5,261 | 6,843 | 5,295 | 4,309 | Upgrade |
Operating Income | 1,450 | 1,274 | 1,531 | 970.77 | 1,525 | Upgrade |
Interest Expense | -728.33 | -628.54 | -390.63 | -311.71 | -397.44 | Upgrade |
Interest & Investment Income | 104.43 | 17.68 | 10.94 | 17.5 | 15.18 | Upgrade |
Earnings From Equity Investments | 4.42 | - | - | -1.33 | 0.01 | Upgrade |
Currency Exchange Gain (Loss) | -221.57 | -197.02 | -245.04 | 202.36 | -89.99 | Upgrade |
Other Non Operating Income (Expenses) | -8.82 | 121.31 | 19.31 | 64.54 | -2.39 | Upgrade |
EBT Excluding Unusual Items | 600.36 | 587.37 | 925.67 | 942.11 | 1,051 | Upgrade |
Gain (Loss) on Sale of Assets | -7.5 | -1.45 | -0.65 | -2.33 | 0.35 | Upgrade |
Asset Writedown | -98.15 | - | -96.78 | - | - | Upgrade |
Other Unusual Items | - | - | -24.46 | - | - | Upgrade |
Pretax Income | 494.71 | 585.92 | 803.77 | 939.79 | 1,051 | Upgrade |
Income Tax Expense | 0.67 | 56.32 | 405.67 | 336.07 | 397.38 | Upgrade |
Earnings From Continuing Operations | 494.05 | 529.61 | 398.1 | 603.72 | 653.58 | Upgrade |
Earnings From Discontinued Operations | -2,075 | -1,578 | - | - | - | Upgrade |
Net Income to Company | -1,581 | -1,049 | 398.1 | 603.72 | 653.58 | Upgrade |
Minority Interest in Earnings | 190.74 | 121.22 | 122.96 | 3.06 | -143.95 | Upgrade |
Net Income | -1,390 | -927.53 | 521.06 | 606.78 | 509.63 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | -56.23 | -43.11 | - | Upgrade |
Net Income to Common | -1,390 | -927.53 | 577.29 | 649.88 | 509.63 | Upgrade |
Net Income Growth | - | - | -14.13% | 19.06% | 68.09% | Upgrade |
Shares Outstanding (Basic) | 173 | 169 | 167 | 141 | 123 | Upgrade |
Shares Outstanding (Diluted) | 175 | 171 | 169 | 143 | 138 | Upgrade |
Shares Change (YoY) | 2.12% | 1.11% | 18.16% | 3.67% | 14.03% | Upgrade |
EPS (Basic) | -8.03 | -5.49 | 3.45 | 4.61 | 4.13 | Upgrade |
EPS (Diluted) | -7.95 | -5.41 | 3.41 | 4.53 | 3.68 | Upgrade |
EPS Growth | - | - | -24.72% | 23.10% | 47.20% | Upgrade |
Free Cash Flow | -157.24 | 784.06 | -934.11 | -683.4 | 335.07 | Upgrade |
Free Cash Flow Per Share | -0.90 | 4.58 | -5.51 | -4.76 | 2.42 | Upgrade |
Gross Margin | 46.69% | 44.95% | 49.80% | 44.38% | 49.15% | Upgrade |
Operating Margin | 8.70% | 8.76% | 9.11% | 6.88% | 12.85% | Upgrade |
Profit Margin | -8.34% | -6.38% | 3.43% | 4.60% | 4.29% | Upgrade |
Free Cash Flow Margin | -0.94% | 5.39% | -5.56% | -4.84% | 2.82% | Upgrade |
EBITDA | 2,051 | 1,952 | 2,072 | 1,455 | 1,890 | Upgrade |
EBITDA Margin | 12.31% | 13.43% | 12.32% | 10.31% | 15.92% | Upgrade |
D&A For EBITDA | 600.61 | 678.4 | 540.66 | 484.71 | 364.44 | Upgrade |
EBIT | 1,450 | 1,274 | 1,531 | 970.77 | 1,525 | Upgrade |
EBIT Margin | 8.70% | 8.76% | 9.11% | 6.88% | 12.85% | Upgrade |
Effective Tax Rate | 0.13% | 9.61% | 50.47% | 35.76% | 37.81% | Upgrade |
Revenue as Reported | 16,810 | 14,695 | 16,874 | 14,451 | 11,921 | Upgrade |
Advertising Expenses | 107.82 | 86.82 | 101.48 | 70.07 | 52.41 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.